Core Insights - Conavi Medical Inc. will participate in the Transcatheter Cardiovascular Therapeutics (TCT) 2025 conference, showcasing its hybrid intravascular imaging technology [1][5] - The company aims to demonstrate how its Novasight Hybrid™ imaging system can enhance procedural decision-making in complex percutaneous coronary interventions (PCI) [2][3] Company Overview - Conavi Medical focuses on intravascular imaging solutions, specifically the Novasight Hybrid™ System, which integrates intravascular ultrasound (IVUS) and optical coherence tomography (OCT) [6] - The first-generation Novasight Hybrid™ System has received regulatory clearance in the U.S., Canada, China, and Japan, and is currently utilized in seven leading cardiovascular care hospitals in North America [3][6] Conference Participation - The TCT 2025 conference will take place from October 25 to 28, 2025, at the Moscone Center in San Francisco, California, where Conavi will have a booth [1][8] - Conavi will also engage in Intravascular Imaging & Training sessions, featuring expert case presentations on guiding challenging PCI procedures [4]
Conavi Medical to Highlight Novasight Hybrid™ Imaging at TCT 2025
Globenewswire·2025-10-23 11:00